2018
DOI: 10.1016/j.biopha.2018.06.084
|View full text |Cite
|
Sign up to set email alerts
|

MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
31
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(31 citation statements)
references
References 25 publications
0
31
0
Order By: Relevance
“…This pathway regulates a broad range of physiological processes such as cell growth, proliferation, differentiation, migration development, inflammatory responses and apoptosis (28) for cells in general, and the progression, invasion, survival and drug resistance in the context of cancer cells. Xu et al demonstrated that MAPK8 promoted resistance to anticancer drug, accelerated cell proliferation and inhibited the apoptosis of glioblastoma cells via activating the MAPK signaling pathway (29). Other studies have reported that in tumor tissue samples derived from patient, extracellular signal-regulated protein kinase (ERK) was phosphorylated, indicating that this survival pathway was active in glioma cells (30).…”
Section: Discussionmentioning
confidence: 99%
“…This pathway regulates a broad range of physiological processes such as cell growth, proliferation, differentiation, migration development, inflammatory responses and apoptosis (28) for cells in general, and the progression, invasion, survival and drug resistance in the context of cancer cells. Xu et al demonstrated that MAPK8 promoted resistance to anticancer drug, accelerated cell proliferation and inhibited the apoptosis of glioblastoma cells via activating the MAPK signaling pathway (29). Other studies have reported that in tumor tissue samples derived from patient, extracellular signal-regulated protein kinase (ERK) was phosphorylated, indicating that this survival pathway was active in glioma cells (30).…”
Section: Discussionmentioning
confidence: 99%
“…KRAS is active in most glioblastomas and necessary for the persistence of glioblastoma tumors in mouse models 57 . It also triggers the oncogenic pathway of MAPK (RAS/RAF/MEK/ERK) in glioblastoma 58 . So, the downregulation of PIK3CA, PIK3CB, KRAS, EGFR, and MYC proteins by miR-429 in our study, suggests a tumor suppressor effect of miR-429 in GBM cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…MAPK1 is a direct target gene of miR-585 that promotes the proliferation and metastasis of gastric cancer [23] .MAPK8, which is also known as JNK, is characterized as a pronounced marked protein, is an important cellular pathway triggered in response to DNA damage, and it was also proved to be associated with tumor progression, including cell survival, migration and autophagy [24] . Sun et al [25] reported that MAPK8 could mediate S/G2 phase cycle arrest and apoptosis, and suppress AKT activation in gastric cancer cells, and dysregulated MAPK8 was observed in several cancers, such as glioblastoma, skin cancer, brain tumor and leukemia [26,27] .…”
Section: Discussionmentioning
confidence: 99%